India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Deal for 100 million doses with additional 100 million through 2023
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
AstraZeneca, Sinopharm and Moderna were part of the study
Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
Complementary business models are the reason for the acquisition
Drug formulations and biologics make impressive gains
Subscribe To Our Newsletter & Stay Updated
